-
1
-
-
0037466923
-
Current and emerging infectious risks of blood transfusions
-
Busch MP, Kleinman SH, Nemo GJ Current and emerging infectious risks of blood transfusions. JAMA 2003; 289: 959-62.
-
(2003)
JAMA
, vol.289
, pp. 959-962
-
-
Busch, M.P.1
Kleinman, S.H.2
Nemo, G.J.3
-
2
-
-
79952707725
-
Adverse blood transfusion outcomes: Establishing causation
-
Isbister JP, Shander A, Spahn D.R., Erhard J., Farmer SL, Hofmann A. Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev 2011; 25: 89-101.
-
(2011)
Transfus Med Rev
, vol.25
, pp. 89-101
-
-
Isbister, J.P.1
Shander, A.2
Spahn, D.R.3
Erhard, J.4
Farmer, S.L.5
Hofmann, A.6
-
3
-
-
80054699488
-
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: A retrospective cohort study
-
Musallam KM, Tamim HM, Richards T, et al Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-407.
-
(2011)
Lancet
, vol.378
, pp. 1396-1407
-
-
Musallam, K.M.1
Tamim, H.M.2
Richards, T.3
-
4
-
-
64949084201
-
Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients
-
Bernard AC, Davenport DL, Chang P.K., Vaughan TB, Zwischenberger JB Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208: 931-37.
-
(2009)
J Am Coll Surg
, vol.208
, pp. 931-937
-
-
Bernard, A.C.1
Davenport, D.L.2
Chang, P.K.3
Vaughan, T.B.4
Zwischenberger, J.B.5
-
5
-
-
0037174359
-
Anemia and blood transfusion in critically ill patients
-
Vincent JL, Baron JF, Reinhart K, et al Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-507.
-
(2002)
JAMA
, vol.288
, pp. 1499-1507
-
-
Vincent, J.L.1
Baron, J.F.2
Reinhart, K.3
-
6
-
-
84864042696
-
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
-
Carson JL, Carless PA, Hebert PC Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4: CD002042.
-
(2012)
Cochrane Database Syst Rev
, vol.4
-
-
Carson, J.L.1
Carless, P.A.2
Hebert, P.C.3
-
7
-
-
84876770704
-
Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration
-
Frank SM, Abazyan B, Ono M., et al Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg 2013; 116: 975-81.
-
(2013)
Anesth Analg
, vol.116
, pp. 975-981
-
-
Frank, S.M.1
Abazyan, B.2
Ono, M.3
-
8
-
-
84876479056
-
Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia
-
Solomon SB, Wang D, Sun J., et al Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia. Blood 2013; 121: 1663-72.
-
(2013)
Blood
, vol.121
, pp. 1663-1672
-
-
Solomon, S.B.1
Wang, D.2
Sun, J.3
-
9
-
-
65349166375
-
Transfusion-related mortality: The ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
-
Vamvakas EC, Blajchman MA Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113: 3406-17.
-
(2009)
Blood
, vol.113
, pp. 3406-3417
-
-
Vamvakas, E.C.1
Blajchman, M.A.2
-
10
-
-
79551552147
-
Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: Nata guidelines
-
Goodnough LT, Maniatis A, Earnshaw P., et al Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22.
-
(2011)
Br J Anaesth
, vol.106
, pp. 13-22
-
-
Goodnough, L.T.1
Maniatis, A.2
Earnshaw, P.3
-
11
-
-
78651377892
-
Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty
-
Na HS, Shin SY, Hwang J.Y., Jeon YT, Kim CS, Do SH Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion 2011; 51: 118-24.
-
(2011)
Transfusion
, vol.51
, pp. 118-124
-
-
Na, H.S.1
Shin, S.Y.2
Hwang, J.Y.3
Jeon, Y.T.4
Kim, C.S.5
Do, S.H.6
-
12
-
-
80055016788
-
Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery
-
Yoo YC, Shim JK, Kim J.C., Jo YY, Lee JH, Kwak YL Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology 2011; 115: 929-37.
-
(2011)
Anesthesiology
, vol.115
, pp. 929-937
-
-
Yoo, Y.C.1
Shim, J.K.2
Kim, J.C.3
Jo, Y.Y.4
Lee, J.H.5
Kwak, Y.L.6
-
13
-
-
79952197748
-
Transfusion in trauma: Thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy
-
Schochl H, Nienaber U, Maegele M., et al Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15: R83.
-
(2011)
Crit Care
, vol.15
-
-
Schochl, H.1
Nienaber, U.2
Maegele, M.3
-
14
-
-
84861379621
-
Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: A quality improvement cycle
-
Kotze A, Carter LA, Scally AJ Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth 2012; 108: 943-52.
-
(2012)
Br J Anaesth
, vol.108
, pp. 943-952
-
-
Kotze, A.1
Carter, L.A.2
Scally, A.J.3
-
15
-
-
84862889184
-
Point-of-care testing: A prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients
-
Weber CF, Gorlinger K, Meininger D., et al Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-47.
-
(2012)
Anesthesiology
, vol.117
, pp. 531-547
-
-
Weber, C.F.1
Gorlinger, K.2
Meininger, D.3
-
16
-
-
84871544047
-
Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: A randomized, placebo-controlled trial
-
Rahe-Meyer N., Solomon C, Hanke A., et al Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013; 118: 40-50.
-
(2013)
Anesthesiology
, vol.118
, pp. 40-50
-
-
Rahe-Meyer, N.1
Solomon, C.2
Hanke, A.3
-
18
-
-
77950277048
-
Activity-based costs of blood transfusions in surgical patients at four hospitals
-
Shander A, Hofmann A, Ozawa S., Theusinger OM, Gombotz H, Spahn DR Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-65.
-
(2010)
Transfusion
, vol.50
, pp. 753-765
-
-
Shander, A.1
Hofmann, A.2
Ozawa, S.3
Theusinger, O.M.4
Gombotz, H.5
Spahn, D.R.6
-
20
-
-
78649753411
-
Detection, evaluation, and management of iron-restricted erythropoiesis
-
Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010; 116: 4754-61.
-
(2010)
Blood
, vol.116
, pp. 4754-4761
-
-
Goodnough, L.T.1
Nemeth, E.2
Ganz, T.3
-
21
-
-
84863807852
-
Iron deficiency syndromes and iron-restricted erythropoiesis
-
Goodnough LT. Iron deficiency syndromes and iron-restricted erythropoiesis. Transfusion 2012; 52: 1584-92.
-
(2012)
Transfusion
, vol.52
, pp. 1584-1592
-
-
Goodnough, L.T.1
-
23
-
-
79951972309
-
2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines
-
Ferraris VA, Brown JR, Despotis G.J., et al 2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-82.
-
(2011)
Ann Thorac Surg
, vol.91
, pp. 944-982
-
-
Ferraris, V.A.1
Brown, J.R.2
Despotis, G.J.3
-
24
-
-
70449503461
-
An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: Safety analysis
-
Stowell CP, Jones SC, Enny C, Langholff W, Leitz G. An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: safety analysis. Spine 2009; 34: 2479-85.
-
(2009)
Spine
, vol.34
, pp. 2479-2485
-
-
Stowell, C.P.1
Jones, S.C.2
Enny, C.3
Langholff, W.4
Leitz, G.5
-
25
-
-
0031036078
-
Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery
-
Sowade O, Warnke H, Scigalla P., et al Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997; 89: 411-18.
-
(1997)
Blood
, vol.89
, pp. 411-418
-
-
Sowade, O.1
Warnke, H.2
Scigalla, P.3
-
26
-
-
76749134292
-
Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: A randomized blind controlled study
-
Weltert L, D'Alessandro S, Nardella S, et al Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg 2010; 139: 621-26.
-
(2010)
J Thorac Cardiovasc Surg
, vol.139
, pp. 621-626
-
-
Weltert, L.1
D'Alessandro, S.2
Nardella, S.3
-
27
-
-
0031406905
-
Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients
-
D'Ambra M.N., Gray RJ, Hillman R, et al Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg 1997; 64: 1686-93.
-
(1997)
Ann Thorac Surg
, vol.64
, pp. 1686-1693
-
-
D'Ambra, M.N.1
Gray, R.J.2
Hillman, R.3
-
28
-
-
0037406140
-
Bloodless medicine: Clinical care without allogeneic blood transfusion
-
Goodnough LT, Shander A, Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion 2003; 43: 668-76.
-
(2003)
Transfusion
, vol.43
, pp. 668-676
-
-
Goodnough, L.T.1
Shander, A.2
Spence, R.3
-
30
-
-
0035686187
-
The rise and fall of preoperative autologous blood donation
-
Brecher ME, Goodnough LT The rise and fall of preoperative autologous blood donation. Transfusion 2001; 41: 1459-62.
-
(2001)
Transfusion
, vol.41
, pp. 1459-1462
-
-
Brecher, M.E.1
Goodnough, L.T.2
-
31
-
-
0036704235
-
A prospective, randomized study of preoperative autologous donation for hip replacement surgery
-
Billote DB, Glisson SN, Green D, Wixson RL A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 2002; 84: 1299-304.
-
(2002)
J Bone Joint Surg Am
, vol.84
, pp. 1299-1304
-
-
Billote, D.B.1
Glisson, S.N.2
Green, D.3
Wixson, R.L.4
-
32
-
-
74849123956
-
Acute normovolemic hemodilution is not beneficial in patients undergoing primary elective valve surgery
-
Virmani S, Tempe DK, Pandey B.C., et al Acute normovolemic hemodilution is not beneficial in patients undergoing primary elective valve surgery. Ann Card Anaesth 2010; 13: 34-38.
-
(2010)
Ann Card Anaesth
, vol.13
, pp. 34-38
-
-
Virmani, S.1
Tempe, D.K.2
Pandey, B.C.3
-
33
-
-
0027018429
-
A controlled trial of intra-operative autologous transfusion in cardiothoracic surgery measuring effect on transfusion requirements and clinical outcome
-
Bell K, Stott K, Sinclair C.J., Walker WS, Gillon J. A controlled trial of intra-operative autologous transfusion in cardiothoracic surgery measuring effect on transfusion requirements and clinical outcome. Transfus Med 1992; 2: 295-300.
-
(1992)
Transfus Med
, vol.2
, pp. 295-300
-
-
Bell, K.1
Stott, K.2
Sinclair, C.J.3
Walker, W.S.4
Gillon, J.5
-
34
-
-
84876132629
-
Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: Results of a randomized comparison
-
Weltert L, Nardella S, Rondinelli M.B., Pierelli L., De Paulis R. Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison. Transfusion 2013; 53: 790-97.
-
(2013)
Transfusion
, vol.53
, pp. 790-797
-
-
Weltert, L.1
Nardella, S.2
Rondinelli, M.B.3
Pierelli, L.4
De Paulis, R.5
-
35
-
-
39049193826
-
Cell salvage for minimising perioperative allogeneic blood transfusion
-
Carless PA, Henry DA, Moxey A.J., O'Connell D L, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2006; 4: CD001888.
-
(2006)
Cochrane Database Syst Rev
, vol.4
-
-
Carless, P.A.1
Henry, D.A.2
Moxey, A.J.3
O'Connell D, L.4
Brown, T.5
Fergusson, D.A.6
-
36
-
-
2942716858
-
Desmopressin for minimising perioperative allogeneic blood transfusion
-
Carless PA, Henry DA, Moxey A.J., et al Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2004; 1: CD001884.
-
(2004)
Cochrane Database Syst Rev
, vol.1
-
-
Carless, P.A.1
Henry, D.A.2
Moxey, A.J.3
-
37
-
-
58149300170
-
Desmopressin reduces transfusion needs after surgery: A meta-analysis of randomized clinical trials
-
Crescenzi G, Landoni G, Biondi-Zoccai G, et al Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. Anesthesiology 2008; 109: 1063-76.
-
(2008)
Anesthesiology
, vol.109
, pp. 1063-1076
-
-
Crescenzi, G.1
Landoni, G.2
Biondi-Zoccai, G.3
-
38
-
-
79955375429
-
Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion
-
Steinlechner B, Zeidler P, Base E., et al Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Ann Thorac Surg 2011; 91: 1420-26.
-
(2011)
Ann Thorac Surg
, vol.91
, pp. 1420-1426
-
-
Steinlechner, B.1
Zeidler, P.2
Base, E.3
-
39
-
-
0345167849
-
Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin
-
Reiter RA, Mayr F, Blazicek H., et al Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood 2003; 102: 4594-99.
-
(2003)
Blood
, vol.102
, pp. 4594-4599
-
-
Reiter, R.A.1
Mayr, F.2
Blazicek, H.3
-
41
-
-
81855194434
-
First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A retrospective, single-center cohort study
-
Gorlinger K, Dirkmann D, Hanke A.A., et al First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115: 1179-91.
-
(2011)
Anesthesiology
, vol.115
, pp. 1179-1191
-
-
Gorlinger, K.1
Dirkmann, D.2
Hanke, A.A.3
-
42
-
-
84867281693
-
Risks of harms using antifibrinolytics in cardiac surgery: Systematic review and network meta-analysis of randomised and observational studies
-
Hutton B, Joseph L, Fergusson D., Mazer CD, Shapiro S, Tinmouth A. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. BMJ 2012; 345: e5798.
-
(2012)
BMJ
, vol.345
-
-
Hutton, B.1
Joseph, L.2
Fergusson, D.3
Mazer, C.D.4
Shapiro, S.5
Tinmouth, A.6
-
43
-
-
44349089188
-
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery
-
Fergusson DA, Hebert PC, Mazer C.D., et al A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-31.
-
(2008)
N Engl J Med
, vol.358
, pp. 2319-2331
-
-
Fergusson, D.A.1
Hebert, P.C.2
Mazer, C.D.3
-
44
-
-
84871949260
-
Current status of pharmacologic therapies in patient blood management
-
Goodnough LT, Shander A. Current status of pharmacologic therapies in patient blood management. Anesth Analg 2013; 116: 15-34.
-
(2013)
Anesth Analg
, vol.116
, pp. 15-34
-
-
Goodnough, L.T.1
Shander, A.2
-
45
-
-
79952270874
-
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
-
Henry DA, Carless PA, Moxey A.J., et al Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; 3: CD001886.
-
(2011)
Cochrane Database Syst Rev
, vol.3
-
-
Henry, D.A.1
Carless, P.A.2
Moxey, A.J.3
-
46
-
-
84861503406
-
Effect of tranexamic acid on surgical bleeding: Systematic review and cumulative meta-analysis
-
Ker K, Edwards P, Perel P., Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054.
-
(2012)
BMJ
, vol.344
-
-
Ker, K.1
Edwards, P.2
Perel, P.3
Shakur, H.4
Roberts, I.5
-
47
-
-
79953163189
-
The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial
-
Roberts I, Shakur H, Afolabi A., et al The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096-101.
-
(2011)
Lancet
, vol.377
, pp. 1096-1101
-
-
Roberts, I.1
Shakur, H.2
Afolabi, A.3
-
48
-
-
50449098285
-
Mechanisms of thrombus formation
-
Furie B, Furie BC Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-49.
-
(2008)
N Engl J Med
, vol.359
, pp. 938-949
-
-
Furie, B.1
Furie, B.C.2
-
49
-
-
84876280594
-
Management of bleeding and coagulopathy following major trauma: An updated european guideline
-
Spahn DR, Bouillon B, Cerny V., et al Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013, 17: R76.
-
(2013)
Crit Care
, vol.17
-
-
Spahn, D.R.1
Bouillon, B.2
Cerny, V.3
-
50
-
-
84865482138
-
Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: Experience with 1974 consecutive trauma patients
-
Holcomb JB, Minei KM, Scerbo M.L., et al Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012; 256: 476-86.
-
(2012)
Ann Surg
, vol.256
, pp. 476-486
-
-
Holcomb, J.B.1
Minei, K.M.2
Scerbo, M.L.3
-
51
-
-
84861451009
-
Association between fibrinogen level and severity of postpartum haemorrhage: Secondary analysis of a prospective trial
-
Cortet M, Deneux-Tharaux C, Dupont C., et al Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 2012; 108: 984-89.
-
(2012)
Br J Anaesth
, vol.108
, pp. 984-989
-
-
Cortet, M.1
Deneux-Tharaux, C.2
Dupont, C.3
-
52
-
-
80053959247
-
Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: A systematic review
-
Kozek-Langenecker S., Sorensen B, Hess J.R., Spahn DR Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 2011; 15: R239.
-
(2011)
Crit Care
, vol.15
-
-
Kozek-Langenecker, S.1
Sorensen, B.2
Hess, J.R.3
Spahn, D.R.4
-
53
-
-
67749122125
-
Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study
-
Karlsson M, Ternstrom L, Hyllner M., et al Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009; 102: 137-44.
-
(2009)
Thromb Haemost
, vol.102
, pp. 137-144
-
-
Karlsson, M.1
Ternstrom, L.2
Hyllner, M.3
-
54
-
-
84874848540
-
Logistics of transfusion support for patients with massive hemorrhage
-
Goodnough LT, Spain DA, Maggio P. Logistics of transfusion support for patients with massive hemorrhage. Curr Opin Anaesthesiol 2013; 26: 208-14.
-
(2013)
Curr Opin Anaesthesiol
, vol.26
, pp. 208-214
-
-
Goodnough, L.T.1
Spain, D.A.2
Maggio, P.3
-
55
-
-
33846423913
-
Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography
-
Rugeri L, Levrat A, David J.S., et al Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007; 5: 289-95.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 289-295
-
-
Rugeri, L.1
Levrat, A.2
David, J.S.3
-
56
-
-
79953280012
-
Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion
-
Afshari A, Wikkelso A, Brok J., Moller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011; 3: CD007871.
-
(2011)
Cochrane Database Syst Rev
, vol.3
-
-
Afshari, A.1
Wikkelso, A.2
Brok, J.3
Moller, A.M.4
Wetterslev, J.5
-
57
-
-
84872773471
-
The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma
-
Innerhofer P, Westermann I, Tauber H., et al The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44: 209-16.
-
(2013)
Injury
, vol.44
, pp. 209-216
-
-
Innerhofer, P.1
Westermann, I.2
Tauber, H.3
-
58
-
-
79953306391
-
Clinical review: Prothrombin complex concentrates - Evaluation of safety and thrombogenicity
-
Sorensen B, Spahn DR, Innerhofer P, Spannagl M., Rossaint R. Clinical review: prothrombin complex concentrates - evaluation of safety and thrombogenicity. Crit Care 2011; 15: R201.
-
(2011)
Crit Care
, vol.15
-
-
Sorensen, B.1
Spahn, D.R.2
Innerhofer, P.3
Spannagl, M.4
Rossaint, R.5
-
59
-
-
79959476160
-
How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage
-
Goodnough LT, Shander A. How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. Blood 2011; 117: 6091-99.
-
(2011)
Blood
, vol.117
, pp. 6091-6099
-
-
Goodnough, L.T.1
Shander, A.2
-
60
-
-
77954403042
-
Prothrombin complex concentrates: An update
-
Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus 2010; 8: 149-54.
-
(2010)
Blood Transfus
, vol.8
, pp. 149-154
-
-
Franchini, M.1
Lippi, G.2
-
61
-
-
84856699090
-
Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th edn: American college of chest physicians evidence-based clinical practice guidelines
-
Guyatt GH, Akl EA, Crowther M, Gutterman D.D., Schuunemann HJ Executive summary: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141 (suppl 2): 7-47.
-
(2012)
Chest
, vol.141
, Issue.SUPPL. 2
, pp. 7-47
-
-
Guyatt, G.H.1
Akl, E.A.2
Crowther, M.3
Gutterman, D.D.4
Schuunemann, H.J.5
-
62
-
-
79955406987
-
Off-label use of recombinant factor VIIa in U.S. Hospitals: Analysis of hospital records
-
Logan AC, Yank V, Stafford RS Off-Label Use of Recombinant Factor VIIa in U.S. Hospitals: Analysis of Hospital Records. Ann Intern Med 2011; 154: 516-22.
-
(2011)
Ann Intern Med
, vol.154
, pp. 516-522
-
-
Logan, A.C.1
Yank, V.2
Stafford, R.S.3
-
63
-
-
79955414221
-
Systematic review: Benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications
-
Yank V, Tuohy CV, Logan A.C., et al Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med 2011; 154: 529-40.
-
(2011)
Ann Intern Med
, vol.154
, pp. 529-540
-
-
Yank, V.1
Tuohy, C.V.2
Logan, A.C.3
-
64
-
-
78049498149
-
Safety of recombinant activated factor VII in randomized clinical trials
-
Levi M, Levy JH, Andersen H.F., Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363: 1791-800.
-
(2010)
N Engl J Med
, vol.363
, pp. 1791-1800
-
-
Levi, M.1
Levy, J.H.2
Andersen, H.F.3
Truloff, D.4
-
65
-
-
84877705084
-
Biology of factor XIII and clinical manifestations of factor XIII deficiency
-
published online Aug 28. doi:10.1111/j.1537-2995.2012.03865.x
-
Levy JH, Greenberg C. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency. Transfusion 2012; published online Aug 28. doi:10.1111/j.1537-2995.2012.03865.x.
-
(2012)
Transfusion
-
-
Levy, J.H.1
Greenberg, C.2
-
66
-
-
32544449648
-
Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation
-
Godje O, Gallmeier U, Schelian M., Grunewald M, Mair H. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006; 54: 26-33.
-
(2006)
Thorac Cardiovasc Surg
, vol.54
, pp. 26-33
-
-
Godje, O.1
Gallmeier, U.2
Schelian, M.3
Grunewald, M.4
Mair, H.5
-
67
-
-
0036284022
-
Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: Implications of a prospective study
-
Gerlach R, Tolle F, Raabe A., Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 2002; 33: 1618-23.
-
(2002)
Stroke
, vol.33
, pp. 1618-1623
-
-
Gerlach, R.1
Tolle, F.2
Raabe, A.3
Zimmermann, M.4
Siegemund, A.5
Seifert, V.6
-
68
-
-
61549127913
-
Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding
-
Korte WC, Szadkowski C, Gahler A., et al Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology 2009; 110: 239-45.
-
(2009)
Anesthesiology
, vol.110
, pp. 239-245
-
-
Korte, W.C.1
Szadkowski, C.2
Gahler, A.3
-
69
-
-
84861796622
-
Recombinant factor XIII: A safe and novel treatment for congenital factor XIII deficiency
-
Inbal A, Oldenburg J, Carcao M., Rosholm A, Tehranchi R, Nugent D. Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency. Blood 2012; 119: 5111-17.
-
(2012)
Blood
, vol.119
, pp. 5111-5117
-
-
Inbal, A.1
Oldenburg, J.2
Carcao, M.3
Rosholm, A.4
Tehranchi, R.5
Nugent, D.6
-
70
-
-
84868301417
-
Hemostats, sealants, and adhesives III: A new update as well as cost and regulatory considerations for components of the surgical toolbox
-
Spotnitz WD, Burks S. Hemostats, sealants, and adhesives III: a new update as well as cost and regulatory considerations for components of the surgical toolbox. Transfusion 2012; 52: 2243-55.
-
(2012)
Transfusion
, vol.52
, pp. 2243-2255
-
-
Spotnitz, W.D.1
Burks, S.2
-
71
-
-
81855185283
-
Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis
-
Singla NK, Gasparis AP, Ballard J.L., et al Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis. J Am Coll Surg 2011; 213: 722-27.
-
(2011)
J Am Coll Surg
, vol.213
, pp. 722-727
-
-
Singla, N.K.1
Gasparis, A.P.2
Ballard, J.L.3
-
72
-
-
84866490453
-
Haemorrhage control in severely injured patients
-
Gruen RL, Brohi K, Schreiber M., et al Haemorrhage control in severely injured patients. Lancet 2012; 380: 1099-108.
-
(2012)
Lancet
, vol.380
, pp. 1099-1108
-
-
Gruen, R.L.1
Brohi, K.2
Schreiber, M.3
-
73
-
-
70449728019
-
Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery
-
Nasso G, Piancone F, Bonifazi R., et al Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg 2009; 88: 1520-26.
-
(2009)
Ann Thorac Surg
, vol.88
, pp. 1520-1526
-
-
Nasso, G.1
Piancone, F.2
Bonifazi, R.3
-
74
-
-
79955958017
-
Hepcidin and iron regulation, 10 years later
-
Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011; 117: 4425-33.
-
(2011)
Blood
, vol.117
, pp. 4425-4433
-
-
Ganz, T.1
-
75
-
-
77953372800
-
Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias
-
Nemeth E. Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Adv Hematol 2010; 2010: 750643.
-
(2010)
Adv Hematol
, vol.2010
, pp. 750643
-
-
Nemeth, E.1
-
76
-
-
77954611973
-
Iron loading and overloading due to ineffective erythropoiesis
-
Tanno T, Miller JL Iron loading and overloading due to ineffective erythropoiesis. Adv Hematol 2010; 2010: 358283.
-
(2010)
Adv Hematol
, vol.2010
, pp. 358283
-
-
Tanno, T.1
Miller, J.L.2
-
77
-
-
34447120059
-
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
-
Peyssonnaux C, Zinkernagel AS, Schuepbach R.A., et al Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 2007; 117: 1926-32.
-
(2007)
J Clin Invest
, vol.117
, pp. 1926-1932
-
-
Peyssonnaux, C.1
Zinkernagel, A.S.2
Schuepbach, R.A.3
-
78
-
-
14744278436
-
Anemia of chronic disease
-
Weiss G, Goodnough LT Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23.
-
(2005)
N Engl J Med
, vol.352
, pp. 1011-1023
-
-
Weiss, G.1
Goodnough, L.T.2
-
79
-
-
84872951347
-
Hepcidin levels predict non-responsiveness to oral iron therapy in patients with iron deficiency anemia
-
Bregman DB, Morris D, Koch T.A., He A., Goodnough LT Hepcidin levels predict non-responsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol 2013, 88: 97-101.
-
(2013)
Am J Hematol
, vol.88
, pp. 97-101
-
-
Bregman, D.B.1
Morris, D.2
Koch, T.A.3
He, A.4
Goodnough, L.T.5
-
80
-
-
0032572913
-
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
-
Besarab A, Bolton WK, Browne J.K., et al The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-90.
-
(1998)
N Engl J Med
, vol.339
, pp. 584-590
-
-
Besarab, A.1
Bolton, W.K.2
Browne, J.K.3
-
81
-
-
33750983605
-
Correction of anemia with epoetin alfa in chronic kidney disease
-
Singh AK, Szczech L, Tang K.L., et al Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-98.
-
(2006)
N Engl J Med
, vol.355
, pp. 2085-2098
-
-
Singh, A.K.1
Szczech, L.2
Tang, K.L.3
-
82
-
-
33751002326
-
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
-
Drueke TB, Locatelli F, Clyne N., et al Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-84.
-
(2006)
N Engl J Med
, vol.355
, pp. 2071-2084
-
-
Drueke, T.B.1
Locatelli, F.2
Clyne, N.3
-
83
-
-
70949108082
-
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
-
Pfeffer MA, Burdmann EA, Chen C.Y., et al A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361: 2019-32.
-
(2009)
N Engl J Med
, vol.361
, pp. 2019-2032
-
-
Pfeffer, M.A.1
Burdmann, E.A.2
Chen, C.Y.3
-
84
-
-
0041627742
-
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: A randomized, double-blind, placebo-controlled study
-
Hedenus M, Adriansson M, San Miguel J, et al Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study. Br J Haematol 2003; 122: 394-403.
-
(2003)
Br J Haematol
, vol.122
, pp. 394-403
-
-
Hedenus, M.1
Adriansson, M.2
San Miguel, J.3
-
85
-
-
24944454286
-
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
-
Leyland-Jones B., Semiglazov V, Pawlicki M., et al Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 2005; 23: 5960-72.
-
(2005)
J Clin Oncol
, vol.23
, pp. 5960-5972
-
-
Leyland-Jones, B.1
Semiglazov, V.2
Pawlicki, M.3
-
86
-
-
80052414508
-
PREPARE trial: A randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel +/- darbepoetin alfa in primary breast cancer-results at the time of surgery
-
Untch M, Fasching PA, Konecny G.E., et al PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel +/- darbepoetin alfa in primary breast cancer-results at the time of surgery. Ann Oncol 2011; 22: 1988-98.
-
(2011)
Ann Oncol
, vol.22
, pp. 1988-1998
-
-
Untch, M.1
Fasching, P.A.2
Konecny, G.E.3
-
87
-
-
0142186283
-
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial
-
Henke M, Laszig R, Rube C., et al Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003; 362: 1255-60.
-
(2003)
Lancet
, vol.362
, pp. 1255-1260
-
-
Henke, M.1
Laszig, R.2
Rube, C.3
-
88
-
-
40549088086
-
Randomized study of the importance of novel erythropoiesis stimulating protein (Aranesp) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): The danish head and neck cancer group DAHANCA 10
-
abstract 6LB
-
Overgaard J, Hoff C, San Hansen H. Randomized study of the importance of novel erythropoiesis stimulating protein (Aranesp) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): The Danish Head and Neck Cancer Group DAHANCA 10. Eur J Cancer 2007; 7 (suppl 5): abstract 6LB.
-
(2007)
Eur J Cancer
, vol.7
, Issue.SUPPL. 5
-
-
Overgaard, J.1
Hoff, C.2
San Hansen, H.3
-
89
-
-
38649128164
-
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12·0 g/dL with erythropoietin vs above 10·0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer
-
Thomas G, Ali S, Hoebers F.J., et al Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12·0 g/dL with erythropoietin vs above 10·0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer. Gynecol Oncol 2008; 108: 317-25.
-
(2008)
Gynecol Oncol
, vol.108
, pp. 317-325
-
-
Thomas, G.1
Ali, S.2
Hoebers, F.J.3
-
90
-
-
34047221511
-
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
-
Wright JR, Ung YC, Julian J.A., et al Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol 2007; 25: 1027-32.
-
(2007)
J Clin Oncol
, vol.25
, pp. 1027-1032
-
-
Wright, J.R.1
Ung, Y.C.2
Julian, J.A.3
-
91
-
-
41949140285
-
Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
-
Smith RE J.r., Aapro MS, Ludwig H, et al Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. J Clin Oncol 2008; 26: 1040-50.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1040-1050
-
-
Smith Jr., R.E.1
Aapro, M.S.2
Ludwig, H.3
-
92
-
-
65449117261
-
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: A meta-analysis of randomised trials
-
Bohlius J, Schmidlin K, Brillant C., et al Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 2009; 373: 1532-42.
-
(2009)
Lancet
, vol.373
, pp. 1532-1542
-
-
Bohlius, J.1
Schmidlin, K.2
Brillant, C.3
-
93
-
-
70249134095
-
Erythroid-stimulating agents in cancer therapy: Potential dangers and biologic mechanisms
-
Hadland BK, Longmore GD Erythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanisms. J Clin Oncol 2009; 27: 4217-26.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4217-4226
-
-
Hadland, B.K.1
Longmore, G.D.2
-
94
-
-
77953629597
-
Absence of functional EpoR expression in human tumor cell lines
-
Swift S, Ellison AR, Kassner P, et al Absence of functional EpoR expression in human tumor cell lines. Blood 2010; 115: 4254-63.
-
(2010)
Blood
, vol.115
, pp. 4254-4263
-
-
Swift, S.1
Ellison, A.R.2
Kassner, P.3
-
95
-
-
77952172809
-
Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells
-
Sinclair AM, Coxon A, McCaffery I., et al Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells. Blood 2010; 115: 4264-72.
-
(2010)
Blood
, vol.115
, pp. 4264-4272
-
-
Sinclair, A.M.1
Coxon, A.2
McCaffery, I.3
-
96
-
-
78549286047
-
American society of hematology/American society of clinical oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
-
Rizzo JD, Brouwers M, Hurley P., et al American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood 2010; 116: 4045-59.
-
(2010)
Blood
, vol.116
, pp. 4045-4059
-
-
Rizzo, J.D.1
Brouwers, M.2
Hurley, P.3
-
97
-
-
84871558330
-
KDIGO clinical practice guideline for anemia in chronic kidney disease
-
Kidney Disease: Improving Global Outcomes
-
Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2012; 2: 311-16.
-
(2012)
Kidney Int Suppl
, vol.2
, pp. 311-316
-
-
-
99
-
-
77958615383
-
Erythropoiesis stimulating agents, blood transfusion, and the practice of medicine
-
Goodnough LT, Shander AS Erythropoiesis stimulating agents, blood transfusion, and the practice of medicine. Am J Hematol 2010; 85: 835-37.
-
(2010)
Am J Hematol
, vol.85
, pp. 835-837
-
-
Goodnough, L.T.1
Shander, A.S.2
-
100
-
-
84875500204
-
Treatment of anemia with darbepoetin alfa in systolic heart failure
-
Swedberg K, Young JB, Anand I.S., et al Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 2013; 368: 1210-19.
-
(2013)
N Engl J Med
, vol.368
, pp. 1210-1219
-
-
Swedberg, K.1
Young, J.B.2
Anand, I.S.3
-
101
-
-
0025356824
-
Diagnosis of iron-deficiency anemia in the elderly
-
Guyatt GH, Patterson C, Ali M., et al Diagnosis of iron-deficiency anemia in the elderly. Am J Med 1990; 88: 205-09.
-
(1990)
Am J Med
, vol.88
, pp. 205-209
-
-
Guyatt, G.H.1
Patterson, C.2
Ali, M.3
-
102
-
-
4944261763
-
Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia
-
Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein H.G., Woodman RC Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104: 2263-68.
-
(2004)
Blood
, vol.104
, pp. 2263-2268
-
-
Guralnik, J.M.1
Eisenstaedt, R.S.2
Ferrucci, L.3
Klein, H.G.4
Woodman, R.C.5
-
103
-
-
34447635386
-
What proportion of patients referred to secondary care with iron deficiency anemia have colon cancer?
-
Raje D, Mukhtar H, Oshowo A., Ingham Clark C. What proportion of patients referred to secondary care with iron deficiency anemia have colon cancer? Dis Colon Rectum 2007; 50: 1211-14.
-
(2007)
Dis Colon Rectum
, vol.50
, pp. 1211-1214
-
-
Raje, D.1
Mukhtar, H.2
Oshowo, A.3
Ingham Clark, C.4
-
104
-
-
33847046008
-
Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy
-
Henry DH, Dahl NV, Auerbach M, Tchekmedyian S., Laufman LR Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. Oncologist 2007; 12: 231-42.
-
(2007)
Oncologist
, vol.12
, pp. 231-242
-
-
Henry, D.H.1
Dahl, N.V.2
Auerbach, M.3
Tchekmedyian, S.4
Laufman, L.R.5
-
105
-
-
84878062805
-
Does plasma therapy have a role in clincial medicine?
-
(in press)
-
Goodnough LT. Does plasma therapy have a role in clincial medicine? Crit Care Med (in press).
-
Crit Care Med
-
-
Goodnough, L.T.1
|